Bimiralisib Terminated Phase 2 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03740100Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations